Madrigal Stock Soars On FDA Approval For The First MASH Treatment
After a bumpy road, Madrigal Pharmaceuticals (MDGL) gained Food and Drug Administration approval for the first-ever MASH treatment, Rezdiffra. On Friday, Madrigal stock surged by double digits as analysts raised their price target on…